Valuation: Boston Scientific Corporation

Market Cap 6.08TCr 5.45TCr 5.01TCr 4.54TCr 8.49TCr 5,77700Cr 8.65TCr 60TCr 24TCr 3,03900Cr 23TCr 22TCr 9,58300Cr P/E 2026 *
17.2x
P/E 2027 * 18.5x
Enterprise Value 7.23TCr 6.47TCr 5.96TCr 5.4TCr 10TCr 6,86400Cr 10TCr 71TCr 29TCr 3,61100Cr 27TCr 27TCr 11,38700Cr EV / Sales 2026 *
3.45x
EV / Sales 2027 * 3.3x
Free-Float
82.47%
Yield 2026 *
-
Yield 2027 * -
1 day-1.66%
1 week-8.12%
1 month-3.83%
3 months-10.16%
6 months-27.13%
Current year-55.97%
1 week 39.57
Extreme 39.57
46.07
1 month 39.57
Extreme 39.57
46.16
Current year 39.57
Extreme 39.57
100.9
1 year 39.57
Extreme 39.57
105.65
3 years 39.57
Extreme 39.57
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Tech/Sci/R&D Officer - 01/09/2009
Director TitleAgeSince
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Director/Board Member 74 15/04/2016
Date Insider Type Main position Quantity % Market Cap. Importance
25/08/26 Buy

Director

2,040 0.0001%
11/08/26 Other

Controller/Auditor

2,930 0.0002%
10/08/26 Other

Chief Financial Officer

9,908 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
-1.66%-8.12%-58.32%-17.99% 6.08TCr
-1.72%+3.44%+22.84%+56.71% 26TCr
-2.00%+0.75%+7.82%+20.94% 16TCr
-3.73%-4.48%-19.14%+64.75% 15TCr
-.--%+2.46%-11.69%-7.41% 5.33TCr
-2.57%+3.30%+11.59%+44.40% 5.3TCr
+0.84%-3.12%+7.47%+62.40% 5.07TCr
-3.47%+1.04%+19.48%+69.17% 4.93TCr
-3.61%+1.99%+32.36%+93.99% 4.55TCr
-18.64%-12.41%+91.02%+115.67% 3.57TCr
Average -3.66%-1.52%+10.34%+50.26% 9.2TCr
Weighted average by Cap. -2.75%-0.33%+7.41%+47.41%

Financials

2026 *2027 *
Net sales 2.1TCr 1.88TCr 1.73TCr 1.57TCr 2.93TCr 1,99100Cr 2.98TCr 21TCr 8.27TCr 1,04700Cr 7.87TCr 7.7TCr 3,30300Cr 2.1TCr 1.88TCr 1.73TCr 1.57TCr 2.93TCr 1,99600Cr 2.99TCr 21TCr 8.29TCr 1,05000Cr 7.89TCr 7.72TCr 3,31200Cr
Net income 354.63Cr 317.6Cr 292.15Cr 264.71Cr 494.8Cr 34TCr 504.07Cr 3.48TCr 1.4TCr 18TCr 1.33TCr 1.3TCr 56TCr 330.7Cr 296.17Cr 272.43Cr 246.84Cr 461.41Cr 31TCr 470.05Cr 3.25TCr 1.3TCr 17TCr 1.24TCr 1.21TCr 52TCr
Net Debt 1.15TCr 1.03TCr 943.79Cr 855.15Cr 1.6TCr 1,08800Cr 1.63TCr 11TCr 4.52TCr 57TCr 4.3TCr 4.21TCr 1,80500Cr 852.47Cr 763.48Cr 702.28Cr 636.32Cr 1.19TCr 81TCr 1.21TCr 8.37TCr 3.36TCr 43TCr 3.2TCr 3.13TCr 1,34300Cr
Projected Income Statement - Annual - Boston Scientific Corporation
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
30/26/30 $41.98 -1.66% 2,24,67,158
29/26/29 $42.69 +0.61% 3,17,55,378
28/26/28 $42.43 -5.84% 6,98,37,060
27/26/27 $45.06 -1.14% 1,51,39,721
26/26/26 $45.58 -0.24% 1,19,28,715
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Boston Scientific Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
41.98USD
Average target price
50.03USD
Spread / Average Target
+19.17%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Boston Scientific Corporation